Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics - 28 Year Stock Price History | ORKA

Historical daily share price chart and data for Oruka Therapeutics since 1997 adjusted for splits and dividends. The latest closing stock price for Oruka Therapeutics as of November 17, 2025 is 28.23.
  • The all-time high Oruka Therapeutics stock closing price was 537822.00 on August 08, 1997.
  • The Oruka Therapeutics 52-week high stock price is 29.98, which is 6.2% above the current share price.
  • The Oruka Therapeutics 52-week low stock price is 5.49, which is 80.6% below the current share price.
  • The average Oruka Therapeutics stock price for the last 52 weeks is 15.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Oruka Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 14.6693 19.9700 28.3000 6.7800 28.2300 45.59%
2024 19.9423 10.8425 30.4900 10.1971 19.3900 76.73%
2023 13.1612 15.6184 16.4574 10.9716 10.9716 -28.27%
2022 14.3803 14.8439 16.3283 11.4233 15.2957 10.23%
2021 21.6059 26.8481 34.2055 13.8758 13.8758 -46.38%
2020 32.2734 36.6580 123.9790 14.9730 25.8800 -29.77%
2019 42.4516 38.3360 97.4534 31.9466 36.8516 -3.87%
2018 85.3777 156.8290 220.7220 32.5275 38.3360 -75.56%
2017 231.6173 314.8200 331.0830 121.9780 156.8290 -52.63%
2016 366.5936 539.0270 555.2910 249.7650 331.0830 -38.71%
2015 692.0252 845.7150 1227.9100 536.7040 540.1890 -30.08%
2014 1184.1881 1406.8100 1837.8000 577.3630 772.5280 -43.45%
2013 1570.7100 2000.4400 4196.0500 975.8250 1366.1500 -26.32%
2012 2787.1503 4879.1200 5074.2900 1122.2000 1854.0700 -62.00%
2011 9120.8648 15369.2000 16052.3000 4830.3300 4879.1200 -68.45%
2010 18075.0274 16003.5000 40106.4000 12880.9000 15466.8000 -2.76%
2009 22630.2274 31226.4000 65624.2000 10978.0000 15905.9000 -47.42%
2008 72731.7261 173697.0000 180528.0000 24395.6000 30250.6000 -83.06%
2007 272267.3705 369838.0000 537822.0000 124906.0000 178576.0000 -54.25%
2006 529727.5339 537822.0000 537822.0000 380572.0000 390330.0000 -27.42%
2005 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
2004 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
2003 441127.8333 242980.0000 537822.0000 207851.0000 537822.0000 111.17%
2002 483198.0198 537822.0000 537822.0000 254690.0000 254690.0000 -52.64%
2001 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
2000 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
1999 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
1998 537822.0000 537822.0000 537822.0000 537822.0000 537822.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.311B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.048B 33.06
Zoetis (ZTS) United States $53.245B 19.06
Takeda Pharmaceutical (TAK) Japan $45.470B 9.28
BeOne Medicines - (ONC) Switzerland $43.363B 212.69
Daiichi Sankyo, - (DSNKY) Japan $42.699B 21.26
Sandoz Group AG (SDZNY) Switzerland $30.385B 0.00
United Therapeutics (UTHR) United States $20.082B 17.67
Merck (MKKGY) Germany $17.810B 10.98
Shionogi (SGIOY) Japan $14.955B 13.73
Neurocrine Biosciences (NBIX) United States $14.443B 34.66
Summit Therapeutics (SMMT) United States $13.904B 0.00
IPSEN (IPSEY) France $12.822B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.019B 0.00
Ionis Pharmaceuticals (IONS) United States $11.589B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.586B 0.00
Corcept Therapeutics (CORT) United States $7.946B 85.84
Stevanato Group S.p.A (STVN) Italy $6.687B 37.42
Grifols, S.A (GRFS) Spain $5.989B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.349B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.049B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.711B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.659B 17.37
Hypermarcas (HYPMY) Brazil $3.040B 20.87
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.849B 9.09
Dyne Therapeutics (DYN) United States $2.684B 0.00
Soleno Therapeutics (SLNO) United States $2.654B 0.00
Ocular Therapeutix (OCUL) United States $2.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.024B 23.98
Guardian Pharmacy Services (GRDN) United States $1.850B 35.62
Harrow (HROW) United States $1.511B 92.71
BioCryst Pharmaceuticals (BCRX) United States $1.491B 88.50
Collegium Pharmaceutical (COLL) United States $1.453B 7.20
Ardelyx (ARDX) United States $1.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.394B 0.00
Enliven Therapeutics (ELVN) United States $1.310B 0.00
Xeris Biopharma Holdings (XERS) United States $1.191B 0.00
Nektar Therapeutics (NKTR) United States $1.153B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Evotec AG (EVO) Germany $1.074B 0.00
Xencor (XNCR) United States $1.066B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
Theravance Biopharma (TBPH) United States $0.881B 37.00
Savara (SVRA) United States $0.875B 0.00
ARS Pharmaceuticals (SPRY) United States $0.812B 0.00
Organogenesis (ORGO) United States $0.774B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.761B 6.80
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
ProKidney (PROK) United States $0.709B 0.00
Esperion Therapeutics (ESPR) United States $0.693B 0.00
KalVista Pharmaceuticals (KALV) United States $0.688B 0.00
Lexeo Therapeutics (LXEO) United States $0.660B 0.00
Aquestive Therapeutics (AQST) United States $0.658B 0.00
4D Molecular Therapeutics (FDMT) United States $0.616B 0.00
Bioventus (BVS) United States $0.608B 12.46
Ironwood Pharmaceuticals (IRWD) United States $0.510B 12.08
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.430B 5.88
Nature's Sunshine Products (NATR) United States $0.370B 22.05
Lyell Immunopharma (LYEL) United States $0.359B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
USANA Health Sciences (USNA) United States $0.351B 9.79
Silence Therapeutics (SLN) United Kingdom $0.323B 0.00
Aldeyra Therapeutics (ALDX) United States $0.304B 0.00
Larimar Therapeutics (LRMR) United States $0.280B 0.00
Avalo Therapeutics (AVTX) United States $0.274B 0.00
Aclaris Therapeutics (ACRS) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.271B 0.00
Achieve Life Sciences (ACHV) Canada $0.233B 0.00
OmniAb (OABI) United States $0.225B 0.00
AleAnna (ANNA) United States $0.220B 0.00
Protara Therapeutics (TARA) United States $0.213B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.139B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Cassava Sciences (SAVA) United States $0.133B 0.00
Relmada Therapeutics (RLMD) United States $0.131B 0.00
Incannex Healthcare (IXHL) Australia $0.123B 0.00
Unicycive Therapeutics (UNCY) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Prelude Therapeutics (PRLD) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Acrivon Therapeutics (ACRV) United States $0.071B 0.00
Plus Therapeutics (PSTV) United States $0.070B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Fractyl Health (GUTS) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
Korro Bio (KRRO) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.38
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
Heatwurx (PCSA) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.56
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00